| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 5 |
| 1 | CETUXIMAB | 4 |
| 2 | CLOZAPINE | 4 |
| 3 | INFLIXIMAB | 4 |
| 4 | OLANZAPINE | 4 |
| 5 | CAPECITABINE | 3 |
| 6 | LEVONORGESTREL | 3 |
| 7 | PAZOPANIB HYDROCHLORIDE | 3 |
| 8 | ADALIMUMAB | 2 |
| 9 | ADALIMUMAB-AATY | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MITOMYCIN | 1 | 0.0003 |
| 1 | CEFOTAXIME INJECTION | 1 | 0.0002 |
| 2 | CLINDAMYCIN PHOSPHATE | 1 | 0.0002 |
| 3 | IRINOTECAN HYDROCHLORIDE | 2 | 0.0002 |
| 4 | TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM | 1 | 0.0001 |
| 5 | AMPICILLIN INJECTION | 1 | 0.0001 |
| 6 | CETUXIMAB | 4 | 0.0001 |
| 7 | AMPICILLIN | 1 | 0.0001 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 1 | 0.0001 |
| 9 | PAZOPANIB HYDROCHLORIDE | 3 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Epidermal Growth Factor Receptor Antagonist [EPC] | 4 | 0.0001 |
| 1 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 5 | 0.0000 |
| 3 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 4 | Integrin Receptor Antagonist [EPC] | 2 | 0.0000 |
| 5 | Interleukin-23 Antagonist [EPC] | 2 | 0.0000 |
| 6 | Erythropoiesis-stimulating Agent [EPC] | 1 | 0.0000 |
| 7 | Glycopeptide Antibacterial [EPC] | 1 | 0.0000 |
| 8 | Nitroimidazole Antimicrobial [EPC] | 1 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 3 | 0.0000 |